Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada.
Ann Surg. 2023 Jul 1;278(1):65-71. doi: 10.1097/SLA.0000000000005509. Epub 2022 Jul 8.
To assess whether the Surgical Apgar Score (SAS) improves re-estimation of perioperative cardiac risk.
The SAS is a novel risk index that integrates three relevant and easily measurable intraoperative parameters (blood loss, heart rate, mean arterial pressure) to predict outcomes. The incremental prognostic value of the SAS when used in combination with standard preoperative risk indices is unclear.
We conducted a retrospective cohort study of adults (18 years and older) who underwent elective noncardiac surgery at a quaternary care hospital in Canada (2009-2014). The primary outcome was postoperative acute myocardial injury. The SAS (range 0-10) was calculated based on intraoperative estimated blood loss, lowest mean arterial pressure, and lowest heart rate documented in electronic medical records. Incremental prognostic value of the SAS when combined with the Revised Cardiac Risk Index was assessed based on discrimination (c-statistic), reclassification (integrated discrimination improvement, net reclassification index), and clinical utility (decision curve analysis).
The cohort included 16,835 patients, of whom 607 (3.6%) patients had acute postoperative myocardial injury. Addition of the SAS to the Revised Cardiac Risk Index improved risk estimation based on the integrated discrimination improvement [2.0%; 95% confidence interval (CI): 1.5%-2.4%], continuous net reclassification index (54%; 95% CI: 46%-62%), and c-index, which increased from 0.68 (95% CI: 0.65-0.70) to 0.75 (95% CI: 0.73-0.77). On decision curve analysis, addition of the SAS to the Revised Cardiac Risk Index resulted in a higher net benefit at all decision thresholds.
When combined with a validated preoperative risk index, the SAS improved the accuracy of cardiac risk assessment for noncardiac surgery. Further research is needed to delineate how intraoperative data can better guide postoperative decision-making.
评估手术 Apgar 评分(SAS)是否能更好地估计围手术期心脏风险。
SAS 是一种新的风险指数,它整合了三个相关且易于测量的术中参数(出血量、心率、平均动脉压)来预测结果。当与标准术前风险指数联合使用时,SAS 的增量预后价值尚不清楚。
我们进行了一项回顾性队列研究,纳入了在加拿大一家四级保健医院接受择期非心脏手术的成年人(18 岁及以上)(2009-2014 年)。主要结局是术后急性心肌损伤。SAS(范围 0-10)是根据电子病历中记录的术中估计出血量、最低平均动脉压和最低心率计算得出的。基于判别(c 统计量)、重新分类(综合判别改善,净重新分类指数)和临床实用性(决策曲线分析)评估 SAS 与修订后的心脏风险指数联合使用时的增量预后价值。
该队列纳入了 16835 例患者,其中 607 例(3.6%)患者发生术后急性心肌损伤。将 SAS 添加到修订后的心脏风险指数中可改善风险估计,基于综合判别改善(2.0%;95%置信区间:1.5%-2.4%)、连续净重新分类指数(54%;95%置信区间:46%-62%)和 c 指数,后者从 0.68(95%置信区间:0.65-0.70)增加到 0.75(95%置信区间:0.73-0.77)。在决策曲线分析中,将 SAS 添加到修订后的心脏风险指数可在所有决策阈值上获得更高的净收益。
当与经过验证的术前风险指数联合使用时,SAS 可提高非心脏手术心脏风险评估的准确性。需要进一步研究以阐明如何更好地利用术中数据来指导术后决策。